Mon 07/24/2023 13:07 PM
Share this article:
Eurazeo is carrying out a dividend recapitalization of French life insurance broker Groupe Premium after canceling the sale of the company earlier this year, sources told Reorg.

The private equity firm pulled the sale after failing to receive bids reaching its targeted valuation multiple of 15x. Groupe Premium’s projected EBITDA in 2023 is €100 million, while it reported €75 million in 2022.

Groupe Premium’s leverage levels are at about 3x, giving Eurazeo room to be able to recapitalize its portfolio company and pay dividends to reward equity investors, sources said.

The company’s existing debt amounts to about €250 million and the new package is expected to be about €400 million, sources said. Barings is the incumbent lender and it is expected that it will club with other lenders, the sources added.

Groupe Premium has grown substantially since Eurazeo acquired a majority stake in the company for about €290 million in 2021. At the time, Eurazeo invested about €100 million in Groupe Premium, while Montefiore Investment and the company’s management re-invested.

Its turnover has increased 80% year over year to €188 million in 2022, according to its website.

Founded in 2000, Groupe Premium is an independent broker for life insurance and retirement savings solutions and offers wealth management consulting.

The company has its headquarters in Paris and employs more than 1,000 people.

Eurazeo declined to comment.

-- Lucía Camblor, Nick Krause
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2023 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!